Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 1261 AL 1275

Body Mass Index and Risk of Parkinson's Disease: A Dose-Response Meta-Analysis of Prospective Studies

Wang YL, Wang YT, Li JF, Zhang YZ, Yin HL, Han B.

PLoS One. 2015 Jun 29;10(6):e0131778. doi: 10.1371/journal.pone.0131778. eCollection 2015.

Deep brain stimulation for chronic pain

Boccard SG, Pereira EA, Aziz TZ.

J Clin Neurosci. 2015 Oct;22(10):1537-43. doi: 10.1016/j.jocn.2015.04.005. Epub 2015 Jun 26.

Gene therapy for neurodegenerative diseases

O'Connor DM, Boulis NM.

Trends Mol Med. 2015 Aug;21(8):504-12. doi: 10.1016/j.molmed.2015.06.001. Epub 2015 Jun 26.

Modulation of the neuronal network activity by P2X receptors and their involvement in neurological disorders

Sáez-Orellana F, Godoy PA, Silva-Grecchi T, Barra KM, Fuentealba J.

Pharmacol Res. 2015 Nov;101:109-15. doi: 10.1016/j.phrs.2015.06.009. Epub 2015 Jun 26.

[Sleep disturbances in Parkinson's disease: characteristics, evaluation and therapeutic approaches]

Faludi B, Janszky J, Komoly S, Kovács N.

Orv Hetil. 2015 Jul 5;156(27):1091-9. doi: 10.1556/650.2015.30191.

Cognitive and neuroanatomical correlates of neuropsychiatric symptoms in Parkinson's disease: A systematic review

Alzahrani H, Venneri A.

J Neurol Sci. 2015 Sep 15;356(1-2):32-44. doi: 10.1016/j.jns.2015.06.037. Epub 2015 Jun 20.

Rhythmic auditory stimulation with visual stimuli on motor and balance function of patients with Parkinson's disease

Song JH, Zhou PY, Cao ZH, Ding ZG, Chen HX, Zhang GB.

Eur Rev Med Pharmacol Sci. 2015;19(11):2001-7.

Gene-based vaccines and immunotherapeutic strategies against neurodegenerative diseases: Potential utility and limitations

Kudrna JJ, Ugen KE.

Hum Vaccin Immunother. 2015;11(8):1921-6. doi: 10.1080/21645515.2015.1065364.

Occurrence, management and outcomes of hip fractures in patients with Parkinson's disease

Critchley RJ, Khan SK, Yarnall AJ, Parker MJ, Deehan DJ.

Br Med Bull. 2015 Sep;115(1):135-42. doi: 10.1093/bmb/ldv029. Epub 2015 Jun 29.

Therapeutic Effects of Bee Venom on Immunological and Neurological Diseases

Hwang DS, Kim SK, Bae H.

Toxins (Basel). 2015 Jun 29;7(7):2413-21. doi: 10.3390/toxins7072413.

Extremely Low Frequency Magnetic Field Exposure and Parkinson's Disease--A Systematic Review and Meta-Analysis of the Data

Huss A, Koeman T, Kromhout H, Vermeulen R.

Int J Environ Res Public Health. 2015 Jun 30;12(7):7348-56. doi: 10.3390/ijerph120707348.

Dopamine transporter imaging in essential tremor with and without parkinsonian features

Waln O, Wu Y, Perlman R, Wendt J, Van AK, Jankovic J.

J Neural Transm (Vienna). 2015 Nov;122(11):1515-21. doi: 10.1007/s00702-015-1419-z. Epub 2015 Jul 2.

Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson's disease patients with chronic pain

Madeo G, Schirinzi T, Natoli S, Pierantozzi M, Stefani A, Dauri M, Pisani A.

J Neurol. 2015 Sep;262(9):2164-70. doi: 10.1007/s00415-015-7823-3. Epub 2015 Jul 2.

A Meta-Analysis of Mesenchymal Stem Cells in Animal Models of Parkinson's Disease

Riecke J, Johns KM, Cai C, Vahidy FS, Parsha K, Furr-Stimming E, Schiess M, Savitz SI.

Stem Cells Dev. 2015 Sep 15;24(18):2082-90. doi: 10.1089/scd.2015.0127. Epub 2015 Jul 2.

The phosphorylation of α-synuclein: development and implication for the mechanism and therapy of the Parkinson's disease

Xu Y, Deng Y, Qing H.

J Neurochem. 2015 Oct;135(1):4-18. doi: 10.1111/jnc.13234. Epub 2015 Aug 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias